img

Global Veterinary Therapeutics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Veterinary Therapeutics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Veterinary Therapeutics market is estimated at 30700 million US$ in 2021 and is expected to reach 41200 million US$ by the end of 2028, growing at a CAGR of 4.3% in the forecast period between 2022 and 2028.

This report studies the Veterinary Therapeutics market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Veterinary Therapeutics in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Anti-inflammatory
Parasiticides
Others

Market Snapshot, By Application
Hospitals
Veterinary Clinics
Drug Stores
Others

Main Market Players Analyzed in this report, including
Zoetis, Inc.
Virbac
Vetoquinol S.A.
Sanofi (Merial Animal Health)
Merck Animal Health
Eli Lilly and Company (Elanco Animal Health)
Dechra Pharmaceuticals PLC
Ceva Sante Animale
Boehringer Ingelheim GmbH
Bayer AG

The study objectives of this report are
To study and analyze the global Veterinary Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Veterinary Therapeutics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Veterinary Therapeutics manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Veterinary Therapeutics market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Veterinary Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Veterinary Therapeutics are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Veterinary Therapeutics Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Veterinary Therapeutics Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Veterinary Therapeutics

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Veterinary Therapeutics Sales Channel and Distributors Analysis
3.3.1 Veterinary Therapeutics Sales Channel
3.3.2 Veterinary Therapeutics Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Veterinary Clinics
3.5 Veterinary Therapeutics Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Veterinary Therapeutics Type Introduction
4.1.1 Anti-inflammatory
4.1.2 Parasiticides
4.1.3 Others
4.2 Global Veterinary Therapeutics Sales by Type 2016-2021
4.3 Global Veterinary Therapeutics Revenue by Type 2016-2021
4.4 Global Veterinary Therapeutics Price by Type 2016-2021

5 Market Segment: by Application
5.1 Veterinary Therapeutics Type Introduction
5.1.1 Hospitals
5.1.2 Veterinary Clinics
5.1.3 Drug Stores
5.1.3 Others
5.2 Global Veterinary Therapeutics Sales by Application 2016-2021
5.3 Global Veterinary Therapeutics Revenue by Application 2016-2021
5.4 Global Veterinary Therapeutics Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Veterinary Therapeutics Market by Region
6.1.1 Global Veterinary Therapeutics Sales by Regions
6.1.2 Global Veterinary Therapeutics Revenue by Regions
6.2 North America Veterinary Therapeutics Market 2016-2021
6.3 Europe Veterinary Therapeutics Market 2016-2021
6.4 Asia Pacific Veterinary Therapeutics Market 2016-2021
6.5 South America Veterinary Therapeutics Market 2016-2021
6.6 Middle East and Africa Veterinary Therapeutics Market 2016-2021

7 North America
7.1 North America Veterinary Therapeutics Market by Country 2016-2021
7.1.1 North America Veterinary Therapeutics Sales by Country
7.1.2 North America Veterinary Therapeutics Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Veterinary Therapeutics Market by Country 2016-2021
8.1.1 Europe Veterinary Therapeutics Sales by Country
8.1.2 Europe Veterinary Therapeutics Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Veterinary Therapeutics Market by Country 2016-2021
9.1.1 Asia Pacific Veterinary Therapeutics Sales by Country
9.1.2 Asia Pacific Veterinary Therapeutics Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Veterinary Therapeutics Market by Country 2016-2021
10.1.1 South America Veterinary Therapeutics Sales by Country
10.1.2 South America Veterinary Therapeutics Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Veterinary Therapeutics Market by Country 2016-2021
11.1.1 Middle East and Africa Veterinary Therapeutics Sales by Country
11.1.2 Middle East and Africa Veterinary Therapeutics Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zoetis, Inc.
12.1.1 Zoetis, Inc. Company Information
12.1.2 Zoetis, Inc. Veterinary Therapeutics Product Portfolio, Specification and Application
12.1.3 Zoetis, Inc. Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Zoetis, Inc. Key Development
12.2 Virbac
12.2.1 Virbac Company Information
12.2.2 Virbac Veterinary Therapeutics Product Portfolio, Specification and Application
12.2.3 Virbac Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Virbac Key Development
12.3 Vetoquinol S.A.
12.3.1 Vetoquinol S.A. Company Information
12.3.2 Vetoquinol S.A. Veterinary Therapeutics Product Portfolio, Specification and Application
12.3.3 Vetoquinol S.A. Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Vetoquinol S.A. Key Development
12.4 Sanofi (Merial Animal Health)
12.4.1 Sanofi (Merial Animal Health) Company Information
12.4.2 Sanofi (Merial Animal Health) Veterinary Therapeutics Product Portfolio, Specification and Application
12.4.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Sanofi (Merial Animal Health) Key Development
12.5 Merck Animal Health
12.5.1 Merck Animal Health Company Information
12.5.2 Merck Animal Health Veterinary Therapeutics Product Portfolio, Specification and Application
12.5.3 Merck Animal Health Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Merck Animal Health Key Development
12.6 Eli Lilly and Company (Elanco Animal Health)
12.6.1 Eli Lilly and Company (Elanco Animal Health) Company Information
12.6.2 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Portfolio, Specification and Application
12.6.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Eli Lilly and Company (Elanco Animal Health) Key Development
12.7 Dechra Pharmaceuticals PLC
12.7.1 Dechra Pharmaceuticals PLC Company Information
12.7.2 Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Portfolio, Specification and Application
12.7.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Eli Lilly and Company (Elanco Animal Health) Key Development
12.9 Boehringer Ingelheim GmbH
12.9.1 Boehringer Ingelheim GmbH Company Information
12.9.2 Boehringer Ingelheim GmbH Veterinary Therapeutics Product Portfolio, Specification and Application
12.9.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Boehringer Ingelheim GmbH Key Development
12.8 Ceva Sante Animale
12.8.1 Ceva Sante Animale Company Information
12.8.2 Ceva Sante Animale Veterinary Therapeutics Product Portfolio, Specification and Application
12.8.3 Ceva Sante Animale Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Ceva Sante Animale Key Development

13 Global Veterinary Therapeutics Market Forecast by Region by Type and by Application
13.1 Global Veterinary Therapeutics Sales, Revenue Forecast 2022-2027
13.2 Global Veterinary Therapeutics Forecast by Regions
13.2.1 Global Veterinary Therapeutics Sales Forecast by Region 2022-2027
13.2.2 Global Veterinary Therapeutics Revenue Forecast by Region 2022-2027
13.3 Global Veterinary Therapeutics Forecast by Type
13.3.1 Global Veterinary Therapeutics Sales Forecast by Type 2022-2027
13.3.2 Global Veterinary Therapeutics Revenue Forecast by Type 2022-2027
13.3.3 Global Veterinary Therapeutics Price Forecast by Type 2022-2027
13.4 Global Veterinary Therapeutics Forecast by Application
13.4.1 Global Veterinary Therapeutics Sales Forecast by Application 2022-2027
13.4.2 Global Veterinary Therapeutics Revenue Forecast by Application 2022-2027
13.4.3 Global Veterinary Therapeutics Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Veterinary Therapeutics Production Specifications
Table 2: Drivers in Veterinary Therapeutics Market
Table 3: Restraints Veterinary Therapeutics Market
Table 4: Opportunity in Veterinary Therapeutics Market
Table 5: Comparion of Alternative and Veterinary Therapeutics
Table 6: Veterinary Therapeutics Raw Materials Key Suppliers List
Table 7: Veterinary Therapeutics Distributors List
Table 8: Veterinary Therapeutics Major Buyers in Hospitals
Table 9: Veterinary Therapeutics Major Buyers in Veterinary Clinics
Table 10: Veterinary Therapeutics Major Buyers in Drug Stores
Table 11: Global Veterinary Therapeutics Sales (K Units) by Type 2016-2021
Table 12: Global Veterinary Therapeutics Sales Market Share by Type 2016-2021
Table 13: Global Veterinary Therapeutics Revenue (Million USD) by Type 2016-2021
Table 14: Global Veterinary Therapeutics Revenue Market Share by Type 2016-2021
Table 15: Global Veterinary Therapeutics Price by Type 2016-2021
Table 16: Global Veterinary Therapeutics Sales (K Units) by Application 2016-2021
Table 17: Global Veterinary Therapeutics Sales Market Share by Application 2016-2021
Table 18: Global Veterinary Therapeutics Revenue (Million USD) by Application 2016-2021
Table 19: Global Veterinary Therapeutics Revenue Market Share by Application 2016-2021
Table 20: Global Veterinary Therapeutics Price by Application 2016-2021
Table 21: Global Veterinary Therapeutics Sales (K Units) by Region 2016-2021
Table 22: Global Veterinary Therapeutics Sales Market Share by Region 2016-2021
Table 23: Global Veterinary Therapeutics Revenue (Million USD) by Region 2016-2021
Table 24: Global Veterinary Therapeutics Revenue Market Share by Region 2016-2021
Table 25: North America Veterinary Therapeutics Sales (K Units) by Country 2016-2021
Table 26: North America Veterinary Therapeutics Sales Market Share by Country 2016-2021
Table 27: North America Veterinary Therapeutics Revenue (Million USD) by Country 2016-2021
Table 28: North America Veterinary Therapeutics Revenue Market Share by Country 2016-2021)
Table 29: Europe Veterinary Therapeutics Sales (K Units) by Country 2016-2021
Table 30: Europe Veterinary Therapeutics Sales Market Share by Country 2016-2021
Table 31: Europe Veterinary Therapeutics Revenue (Million USD) by Country 2016-2021
Table 32: Europe Veterinary Therapeutics Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Veterinary Therapeutics Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Veterinary Therapeutics Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Veterinary Therapeutics Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Veterinary Therapeutics Revenue Market Share by Country 2016-2021)
Table 37: South America Veterinary Therapeutics Sales (K Units) by Country 2016-2021
Table 38: South America Veterinary Therapeutics Sales Market Share by Country 2016-2021
Table 39: South America Veterinary Therapeutics Revenue (Million USD) by Country 2016-2021
Table 40: South America Veterinary Therapeutics Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Veterinary Therapeutics Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Veterinary Therapeutics Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Veterinary Therapeutics Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Veterinary Therapeutics Revenue Market Share by Country 2016-2021)
Table 45 Zoetis, Inc. Company Information
Table 46 Zoetis, Inc. Veterinary Therapeutics Product Portfolio, Specification and Application
Table 47 Zoetis, Inc. Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Virbac Company Information
Table 49 Virbac Veterinary Therapeutics Product Portfolio, Specification and Application
Table 50 Virbac Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Vetoquinol S.A. Company Information
Table 52 Vetoquinol S.A. Veterinary Therapeutics Product Portfolio, Specification and Application
Table 53 Vetoquinol S.A. Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Sanofi (Merial Animal Health) Company Information
Table 55 Sanofi (Merial Animal Health) Veterinary Therapeutics Product Portfolio, Specification and Application
Table 56 Sanofi (Merial Animal Health) Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Merck Animal Health Company Information
Table 58 Merck Animal Health Veterinary Therapeutics Product Portfolio, Specification and Application
Table 59 Merck Animal Health Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Eli Lilly and Company (Elanco Animal Health) Company Information
Table 61 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Product Portfolio, Specification and Application
Table 62 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Dechra Pharmaceuticals PLC Company Information
Table 64 Dechra Pharmaceuticals PLC Veterinary Therapeutics Product Portfolio, Specification and Application
Table 65 Dechra Pharmaceuticals PLC Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Ceva Sante Animale Company Information
Table 67 Ceva Sante Animale Veterinary Therapeutics Product Portfolio, Specification and Application
Table 68 Ceva Sante Animale Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Boehringer Ingelheim GmbH Company Information
Table 70 Boehringer Ingelheim GmbH Veterinary Therapeutics Product Portfolio, Specification and Application
Table 71 Boehringer Ingelheim GmbH Veterinary Therapeutics Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Veterinary Therapeutics Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Veterinary Therapeutics Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Veterinary Therapeutics Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Veterinary Therapeutics Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Veterinary Therapeutics Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Veterinary Therapeutics Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Veterinary Therapeutics Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Veterinary Therapeutics Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Veterinary Therapeutics Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Veterinary Therapeutics Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Veterinary Therapeutics Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Veterinary Therapeutics Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Veterinary Therapeutics Picture
Figure 2: Global Veterinary Therapeutics Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Veterinary Therapeutics Supply Chain Analysis
Figure 5: Veterinary Therapeutics Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Anti-inflammatory
Figure 7: Product Picture of Parasiticides
Figure 8: Global Veterinary Therapeutics Sales Market Share by Type, 2020
Figure 9: Global Veterinary Therapeutics Revenue Market Share by Type, 2020
Figure 10: Veterinary Therapeutics in Hospitals
Figure 11: Global Veterinary Therapeutics Market: Hospitals 2016-2021
Figure 12: Veterinary Therapeutics in Veterinary Clinics
Figure 13: Global Veterinary Therapeutics Market: Veterinary Clinics 2016-2021
Figure 14: Global Veterinary Therapeutics Sales Market Share by Application, 2020
Figure 15: Global Veterinary Therapeutics Revenue Market Share by Application, 2020
Figure 16: Global Veterinary Therapeutics Sales Market Share by Region 2016-2021
Figure 17: Global Veterinary Therapeutics Revenue Market Share by Region 2016-2021
Figure 18: North America Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 19: North America Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 20: Europe Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 21: Europe Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 24: South America Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 25: South America Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 28: North America Veterinary Therapeutics Sales Market Share by Country, 2020
Figure 29: North America Veterinary Therapeutics Revenue Market Share by Country, 2020
Figure 30: United States Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 31: United States Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 32: Canada Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 33: Canada Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 35: Mexico Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 36: Europe Veterinary Therapeutics Sales Market Share by Country, 2020
Figure 37: Europe Veterinary Therapeutics Revenue Market Share by Country, 2020
Figure 38: Germany Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 39: Germany Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 40: France Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 41: France Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 42: UK Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 43: UK Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 44: Italy Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 45: Italy Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 46: Russia Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 46: Russia Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 47: Spain Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 48: Spain Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Veterinary Therapeutics Sales Market Share by Country, 2020
Figure 50: Asia Pacific Veterinary Therapeutics Revenue Market Share by Country, 2020
Figure 51: China Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 52: China Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 53: Japan Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 54: Japan Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 55: Korea Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 56: Korea Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 59: India Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 60: India Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 61: Australia Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 62: Australia Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 63: South America Veterinary Therapeutics Sales Market Share by Country, 2020
Figure 64: South America Veterinary Therapeutics Revenue Market Share by Country, 2020
Figure 65: Brazil Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 66: Brazil Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 68: Argentina Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 70: Colombia Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Veterinary Therapeutics Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Veterinary Therapeutics Revenue Market Share by Country, 2020
Figure 73: Turkey Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 74: Turkey Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Veterinary Therapeutics Sales (K Units) Status 2016-2021
Figure 78: South Africa Veterinary Therapeutics Revenue (Million USD) Status 2016-2021
Figure 79: Zoetis, Inc. Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 80: Virbac Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 81: Vetoquinol S.A. Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 82: Sanofi (Merial Animal Health) Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 83: Merck Animal Health Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 84: Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 85: Dechra Pharmaceuticals PLC Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 86: Ceva Sante Animale Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 87: Boehringer Ingelheim GmbH Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 88: Bayer AG Veterinary Therapeutics Revenue Market Share Globally (2019-2021)
Figure 89: Global Veterinary Therapeutics Sales (K Units) Forecast (2022-2027)
Figure 90: Global Veterinary Therapeutics Sales (K Units) Forecast (2022-2027)